One68 Global Capital, LLC Altimmune, Inc. Transaction History

One68 Global Capital, LLC

  • $0
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$8.74 - $16.45 $94,514 - $177,890
-10,814 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$7.84 - $14.22 $84,781 - $153,775
10,814 New
10,814 $122,000
Q1 2020

May 15, 2020
SELL
$1.69 - $3.8 $23,247 - $52,272
-13,756 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$1.53 - $2.15 $21,046 - $29,575
13,756 New
13,756 $1,000

Others Institutions Holding ALT

# of Institutions
186
Shares Held
39.3M
Call Options Held
913K
Put Options Held
743K
View Full List

About Altimmune, Inc.

ALT Quotes by TradingView
  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $404M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track One68 Global Capital, LLC Portfolio

Follow One68 Global Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of One68 Global Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on One68 Global Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email